Biomarker responses during mid-term mechanical cardiac support in children.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  The Journal of Heart and Lung Transplantation

• Publication date

  2008-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.healun.2007.11.564PMID 18267220
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of cardiac surgery on plasma levels of B-type natriuretic peptide in children with congenital heart disease.

  2007cited by this paper
• Improvement in survival after mechanical circulatory support with pneumatic pulsatile ventricular assist devices in pediatric patients.

  2006cited by this paper
• What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination?

  2006cited by this paper
• Technology Insight: use of ventricular assist devices in children

  2006cited by this paper
• Aminoterminal B-type pro-natriuretic peptide as a marker of recovery after high-risk coronary artery bypass grafting in patients with ischemic heart disease and severe impaired left ventricular function.

  2006cited by this paper
• Plasma Concentrations of N-Terminal Brain Natriuretic Peptide in Healthy Children, Adolescents, and Young Adults: Effect of Age and Gender

  2006cited by this paper
• Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.

  2006cited by this paper
• N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart failure.

  2006cited by this paper
• Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease.

  2005cited by this paper
• Clinical value of NT-ProBNP and BNP in pediatric cardiology.

  2005cited by this paper
• Pneumatic pulsatile ventricular assist devices in children under 1 year of age.

  2005cited by this paper
• Long-Term Results in Patients With Idiopathic Dilated Cardiomyopathy After Weaning From Left Ventricular Assist Devices

  2005cited by this paper
• Incidence of normal values of natriuretic peptides in patients with chronic heart failure and impact on survival: A direct comparison of N‐terminal atrial natriuretic peptide, N‐terminal brain natriuretic peptide and brain natriuretic peptide

  2005cited by this paper
• Natriuretic peptides and E-selectin as predictors of acute deterioration in patients with inotrope-dependent heart failure.

  2005cited by this paper
• Increased plasma levels of natriuretic peptide type B and A in children with congenital heart defects with left compared with right ventricular volume overload or pressure overload

  2005cited by this paper
• Long-term outcome in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices

  2005cited by this paper
• What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease?

  2005cited by this paper
• Natriuretic peptides and heart disease in infants and children.

  2005cited by this paper
• Effect of cardiopulmonary bypass and surgical intervention on the natriuretic hormone system in children.

  2005cited by this paper
• The association between NT-proBNP levels, functional capacity and stage in patients with heart failure

  2005cited by this paper
• The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.

  2005cited by this paper
• Plasma neurohormone levels correlate with left ventricular functional and morphological improvement in LVAD patients.

  2005cited by this paper
• Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma.

  2004cited by this paper
• B-type natriuretic peptide (BNP) and N-terminal proBNP in patients with end-stage heart failure supported by a left ventricular assist device.

  2004cited by this paper
• Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.

  2004cited by this paper
• Consumption of blood products during mechanical circulatory support in children: comparison between ECMO and a pulsatile ventricular assist device

  2004cited by this paper
• N‐terminal pro‐B‐type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases

  2004cited by this paper
• Natriuretic peptide system: physiology and clinical utility

  2004cited by this paper
• Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure.

  2004cited by this paper
• Clinical signs of heart failure are associated with increased levels of natriuretic peptide types B and A in children with congenital heart defects or cardiomyopathy

  2004cited by this paper
• Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides.

  2004cited by this paper
• Normal values of B type natriuretic peptide in infants, children, and adolescents

  2003cited by this paper
• Plasma N-terminal pro-B-type natriuretic peptide concentrations in a control population of infants and children.

  2003cited by this paper
• Heart transplantation in children after mechanical circulatory support with pulsatile pneumatic assist device.

  2003cited by this paper
• Pulsatile mechanical cardiac assistance in pediatric patients with the Berlin heart ventricular assist device.

  2003cited by this paper
• B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure

  2002cited by this paper
• Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure.

  2002cited by this paper
• Atrial Natriuretic Peptide Prohormone Gene Expression: Hormones and Diseases That Upregulate its Expression

  2002cited by this paper
• The time course of natriuretic hormones as plasma markers of myocardial recovery in heart transplant candidates during ventricular assist device support reveals differences among device types.

  2001cited by this paper
• Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems.

  2001cited by this paper
• Analysis of sympathetic nerve activity in end-stage cardiomyopathy patients receiving left ventricular support.

  2001cited by this paper
• Deloading of the Left Ventricle by Ventricular Assist Device Normalizes Increased Expression of Endothelin ETA Receptors But Not Endothelin-Converting Enzyme-1 in Patients With End-Stage Heart Failure

  2000cited by this paper
• Plasma levels of N-terminal proatrial natriuretic peptide in children are dependent on renal function and age

  2000cited by this paper
• Hormones and hemodynamics in heart failure.

  1999cited by this paper
• Children may survive severe myocarditis with prolonged use of biventricular assist devices

  1999cited by this paper
• Pulsatile pediatric ventricular assist devices: Current results for bridge to transplantation.

  1999cited by this paper
• Brain natriuretic peptide versus atrial natriuretic peptide--physiological and pathophysiological significance in children and adults: a review.

  1996cited by this paper

• Does the ST2 Level in Pediatric Heart Failure Patients Correlate with Cardiovascular Events and Mortality?

  2024cites this paper
• Monitoring MCS patients on the intensive care unit: integrating haemodynamic assessment, laboratory data, and imaging techniques for timely detection of deterioration and recovery

  2023cites this paper
• Invited commentary on: Myocardial recovery in children supported with a durable ventricular assist device - a systematic approach.

  2023cites this paper
• On-admission plasma levels of BNP, MR-proADM, and cTnI in pediatric heart failure: contributions to diagnosis, prognosis, and outcome

  2021cites this paper
• Mechanical Circulatory Support

  2019cites this paper
• BNP response during Berlin Heart® support in child: a case report.

  2017cites this paper
• Biomarkers in Pediatric Cardiac Critical Care

  2016cites this paper
• Paediatric mechanical circulatory support with Berlin Heart EXCOR: development and outcome of a 23-year experience.

  2016cites this paper
• Diagnostic performance and reference values of novel biomarkers of paediatric heart failure

  2016cites this paper
• BNP in children with congenital cardiac disease: is there now sufficient evidence for its routine use?

  2015cites this paper
• Circulating biomarker responses to medical management vs. mechanical circulatory support in severe inotrope‐dependent acute heart failure

  2015cites this paper
• The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update

  2014cites this paper
• Biomarkers of progression, recovery, and remodeling in acute heart failure

  2014cites this paper
• Relationship Between Natriuretic Peptides and Hemodynamic Parameters Following Heart Surgery in Infancy

  2012cites this paper
• Chronic Heart Failure in Children

  2012cites this paper
• Alternatives to heart transplantation: integration of biology with surgery.

  2011cites this paper
• Effectiveness of serial increases in amino-terminal pro-B-type natriuretic peptide levels to indicate the need for mechanical circulatory support in children with acute decompensated heart failure.

  2011cites this paper
• Single-center experience with treatment of cardiogenic shock in children by pediatric ventricular assist devices.

  2011cites this paper
• Interpretation and Use of Natriuretic Peptides in Non-Congestive Heart Failure Settings

  2010cites this paper
• Brain natriuretic peptide is removed by continuous veno-venous hemofiltration in pediatric patients.

  2009cites this paper